Vorolanib Uses, Dosage, Side Effects and more
Vorolanib is under investigation in clinical trial NCT03904719 (CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)).
Trade Name | Vorolanib |
Generic | Vorolanib |
Vorolanib Other Names | Vorolanib |
Type | |
Formula | C23H26FN5O3 |
Weight | Average: 439.491 Monoisotopic: 439.20196788 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |